10 20 30 40 50 60 70 80 1N9U - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER SIGNALING PROTEIN 26-NOV-02 1N9U
TITLE DIFFERENCES AND SIMILARITIES IN SOLUTION STRUCTURES OF ANGIOTENSIN I & TITLE 2 II: IMPLICATION FOR STRUCTURE-FUNCTION RELATIONSHIP
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANGIOTENSIN I; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ANG I; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE PEPTIDE WAS MADE THROUGH SOLID PHASE SYNTHESIS SOURCE 4 USING FMOC CHEMISTRY. THE SEQUENCE OF THE PEPTIDE IS NATURALLY FOUND SOURCE 5 IN HOMO SAPIENS.
KEYWDS ANGIOTENSIN, RENIN-ANGIOTENSIN SYSTEM, SOLID PHASE PEPTIDE SYNTHESIS, KEYWDS 2 NMR SOLUTION STRUCTURE, PEPTIDES, SIGNALING PROTEIN
EXPDTA SOLUTION NMR
NUMMDL 21
AUTHOR G.A.SPYROULIAS,P.NIKOLAKOPOULOU,A.TZAKOS,I.P.GEROTHANASSIS,V.MAGAFA, AUTHOR 2 E.MANESSI-ZOUPA,P.CORDOPATIS
REVDAT 3 21-DEC-16 1N9U 1 TITLE VERSN REVDAT 2 24-FEB-09 1N9U 1 VERSN REVDAT 1 29-JUL-03 1N9U 0
JRNL AUTH G.A.SPYROULIAS,P.NIKOLAKOPOULOU,A.TZAKOS,I.P.GEROTHANASSIS, JRNL AUTH 2 V.MAGAFA,E.MANESSI-ZOUPA,P.CORDOPATIS JRNL TITL COMPARISON OF THE SOLUTION STRUCTURES OF ANGIOTENSIN I & II. JRNL TITL 2 IMPLICATION FOR STRUCTURE-FUNCTION RELATIONSHIP. JRNL REF EUR.J.BIOCHEM. V. 270 2163 2003 JRNL REFN ISSN 0014-2956 JRNL PMID 12752436 JRNL DOI 10.1046/J.1432-1033.2003.03573.X
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.M.MATSOUKAS,J.HONDRELIS,M.KERAMIDA,T.MAVROMOUSTAKOS, REMARK 1 AUTH 2 A.MAKRIYANNIS,R.YAMDAGNI,Q.WU,G.J.MOORE REMARK 1 TITL ROLE OF THE NH2-TERMINAL DOMAIN OF ANGIOTENSIN II (ANG II) REMARK 1 TITL 2 AND [SAR1]ANGIOTENSIN II ON CONFORMATION AND ACTIVITY. NMR REMARK 1 TITL 3 EVIDENCE FOR AROMATIC RING CLUSTERING AND PEPTIDE BACKBONE REMARK 1 TITL 4 FOLDING COMPARED WITH [DES-1,2,3]ANGIOTENSIN II REMARK 1 REF J.BIOL.CHEM. V. 269 5303 1994 REMARK 1 REFN ISSN 0021-9258
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : AMBER 5.0 REMARK 3 AUTHORS : KOLLMAN, CASE, MERZ, CHEATHAM, SIMMERLING, DARDEN, REMARK 3 PEARLMAN REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THIS STRUCTURE IS BASED ON A 225 NOE- REMARK 3 DERIVED DISTANCE CONSTRAINTS, 7 DIHEDRAL ANGLE RESTRAINTS, 1 REMARK 3 DISTANCE RESTRAINT FROM HYDROGEN BOND
REMARK 4 REMARK 4 1N9U COMPLIES WITH FORMAT V. 3.15, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-DEC-02. REMARK 100 THE RCSB ID CODE IS RCSB017698.
REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2.5 MM; DMSO-D6 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : DQF-COSY; 2D TOCSY; 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 400 MHZ REMARK 210 SPECTROMETER MODEL : DPX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XWINNMR 2.6, XEASY 1.3, DYANA 1.5 REMARK 210 METHOD USED : SIMULATED ANNEALING, TORSION REMARK 210 ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 300 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 21 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION FOR MODELS 1-20, REMARK 210 MEAN ENERGY MINIMIZED FOR MODEL 21 REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 21 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES. MODELS 1-20 ARE THE FAMILY ENSEMBLE, REMARK 210 WHILE MODEL 21 IS THE MINIMIZED AVERAGE STRUCTURE DERIVED FROM REMARK 210 THAT ENSEMBLE.
REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PHE A 8 117.36 -171.75 REMARK 500 1 HIS A 9 58.75 -149.53 REMARK 500 2 PHE A 8 118.30 -171.58 REMARK 500 2 HIS A 9 56.59 -146.96 REMARK 500 3 PHE A 8 118.30 -171.58 REMARK 500 3 HIS A 9 56.59 -146.96 REMARK 500 4 PHE A 8 119.30 -171.72 REMARK 500 4 HIS A 9 64.97 -151.55 REMARK 500 5 PHE A 8 117.86 -171.89 REMARK 500 6 PHE A 8 118.93 -171.07 REMARK 500 6 HIS A 9 58.33 -148.27 REMARK 500 7 PHE A 8 119.21 -172.11 REMARK 500 7 HIS A 9 59.63 -148.35 REMARK 500 8 PHE A 8 117.84 -170.91 REMARK 500 8 HIS A 9 65.66 -151.10 REMARK 500 9 PHE A 8 118.31 -171.91 REMARK 500 10 PHE A 8 119.85 -170.43 REMARK 500 11 PHE A 8 118.80 -171.77 REMARK 500 12 PHE A 8 120.14 -171.48 REMARK 500 13 PHE A 8 118.31 -172.61 REMARK 500 14 PHE A 8 119.07 -171.25 REMARK 500 14 HIS A 9 58.30 -151.60 REMARK 500 15 PHE A 8 117.20 -171.72 REMARK 500 16 PHE A 8 117.45 -171.92 REMARK 500 16 HIS A 9 63.70 -151.34 REMARK 500 17 PHE A 8 119.55 -171.81 REMARK 500 17 HIS A 9 61.79 -153.46 REMARK 500 18 PHE A 8 119.22 -172.14 REMARK 500 18 HIS A 9 57.10 -149.75 REMARK 500 19 PHE A 8 118.47 -171.24 REMARK 500 19 HIS A 9 63.29 -150.37 REMARK 500 20 PHE A 8 115.71 -170.95 REMARK 500 20 HIS A 9 35.98 -153.52 REMARK 500 21 PHE A 8 122.61 -170.23 REMARK 500 21 HIS A 9 59.70 -153.61 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 14 ARG A 2 0.10 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL
DBREF 1N9U A 1 10 UNP P01019 ANGT_HUMAN 34 43
SEQRES 1 A 10 ASP ARG VAL TYR ILE HIS PRO PHE HIS LEU
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000